AOF Proteins
Biologics and Insulin Manufacturing
Cell Culture Media
Cultured Meat
Growth Factors
Stem Cell Culture
Vaccine
>>
Rc Carboxypeptidase B
Rc Carboxypeptidase B
Carboxypeptidase B is a 34.5 kDa exoprotease with specificity for basic amino acids such as Lysine, Arginine, and Ornithine.
It is 307 amino acids long — expressed in Pichia Pastoris — and is manufactured using recombinant DNA technology and AOF process at our GMP-certified facility.
Manufacturing of active pharmaceutical ingredients such as insulin
Sequence analysis by successive cleavage of C-terminal basic amino acids
Antibody quality control
100% AOF
Zero risk of contamination by adventitious agents
High purity; free of contaminating proteases such as Chymotrypsin and Carboxypeptidase A
Description: Colorless, white to off-white,and clear liquid
pH: 7.0 to 8.9
Protein content by A 280: 2.5 to 3.5 mg/ml
Purity by SDS PAGE: ≥ 90% (Major band ≈ 34KDa)
Specific activity (Hippuryl-L-Arginine): > 170 units/ mg of protein
Trypsin (BAEE): Undetectable
Microbial limit tests:
TVAC: <100 cfu/ml
TYMC: <10 cfu/ml
Pathogens:
E. Coli: Shall be absent
Salmonella sp: Shall be absent
Pseudomonas aeruginosa: Shall be absent
Staphylococcus aureus: Shall be absent
Description: White to off-white odourless powder
Solubility: 0.3% solution in water is clear
Protein content by A280: NLT 0.35 mg/mg of powder
Purity by SDS PAGE: NLT 90% (Major band ≈ 34 KDa)
Specific activity (Hippuryl-L-Arginine): > 170 units/mg of protein
Engineer, MBA (ISB) and Entrepreneur with 20+ years of experience in biotech innovation/product development and large scale biomanufacturing.
Follow me on:
Krishna Kalyan
Executive Director & COO
Follow me on:
Rajesh Krishnamurthy
Executive Director & CEO
Follow me on:
RAJARAM IYER
Non-Executive Director
Rajaram has 22+ years of progressive experience in Strategic Planning, Business Development, Portfolio Management and establishing new businesses. He leads the global portfolio management for Laurus. Before joining Laurus, he was associated with Mankind Pharma, Aurobindo Pharma, Dr. Reddys Laboratories and Torrent Pharmaceuticals. Mr Rajaram has a Master’s degree in Analytical Chemistry. He has also completed EGMP from IIM—Bangalore and an MBA in Operations Research.
Dr. V Uma Maheswer Rao
Non-Executive Director
Dr. V Uma Maheswer Rao has been associated with Laurus Labs since June 9, 2016. He holds a Master’s degree in Science and a Ph.D from Osmania University. He has several years of experience in the fields of process research and development and API manufacturing process.
V.V Ravi Kumar
Non-Executive Director
V V Ravi Kumar is the Executive whole time Director and Chief Financial Officer of Laurus Labs. He has been a Director of Laurus Labs since November 30, 2006 and is in-charge of finance and human resources function of the company, he has also led the supply chain function of our company for a significant period of time.
DR. SATYANARAYANA CHAVA
CHAIRMAN
Dr. Satyanarayana Chava is the Executive whole time Director and Chief Executive Officer of Laurus Labs. He has been a Director of Laurus Labs since January 21, 2006. He holds a Bachelor’s and Master’s degree in Science from Andhra University. He was also a research scholar at the College of Science and Technology, Andhra University from 1985 to 1992 and went on to obtain his Ph.D. in the year 1992.